Processes for preparing oxathiazin-like compounds
AssigneeGeistlich Pharma AG
InventorsRolf W. Pfirrmann, Hanns Moehler, Thomas Mueller
Life of this patent
Estimating the term…
Abstract
Oxathiazin-like compounds, processes for making new oxathiazin-like compounds, compounds useful for making oxathiazin-like compounds, and their uses are disclosed. Processes of treating patients suffering from cancers, bacterial infections, fungal infections and/or viral infections by administering oxathiazin-like compounds are also disclosed. These compounds were found to have significantly longer half-life compared to taurolidine and taurultam.
Claims20
A method of reducing or inhibiting cancer cell migration in a subject having a pancreatic cancer, an ovarian cancer, or a squamous cell carcinoma comprising administering an effective amount of a compound of formula I
- wherein R is H, an alkyl, or benzyl, to the subject.
A method of treating a subject having a squamous cell carcinoma, an ovarian cancer, or a pancreatic cancer comprising orally, intravenously, or topically administering 0.1 g to about 100 g of a compound of formula I
- wherein R is H, an alkyl, or benzyl, to the subject.
Dependencies are inferred from the claim text.